Aging and HIV: Issues, Screening, and Management in Individuals with HIV as They Age

Aging and HIV: Issues, Screening, and Management in Individuals with HIV as They Age

Registration Details

  • Preregistration: $35.00 (USD)
  • Preregistration ends: Friday, June 25, 2021

Faculty

Constance A. Benson, MD
University of California San Diego
R. Douglas Bruce
R. Douglas Bruce, MD, MA, MS
Boston University
Kristine M. Erlandson, MD, MS
University of Colorado Denver
Matthew J. Feinstein, MD, MSc
Northwestern University
Charles W. Flexner, MD
The Johns Hopkins University School of Medicine
Steven C. Johnson, MD
University of Colorado School of Medicine
Victor G. Valcour, MD, PhD
University of California San Francisco
Paul A. Volberding, MD
University of California San Francisco

June 25, 2021

8:30 AM - 1:25 PM PT

List of Topics

  • Assessing Frailty in Older People With HIV
  • Neurocognition and the Aging Brain
  • Cardiovascular Complications of HIV
  • Identifying, Managing, and Preventing Polypharmacy in Older Patients With HIV: A Case-Based Presentation
  • Primary Care Concerns for the Aging Population
  • Managing Pain in Elderly Patients

Agenda

Last Modified: Jun 4, 2021 @ 11:06 AM

Program Description

This course will cover the unique issues and challenges in providing care for people with HIV as they age.

Assessment of Needs

Rapid advances in HIV disease management require the ongoing attention of practitioners involved in HIV medicine. This course will address the implications of new information on strategies for clinical management. Information will be presented through a mix of didactic lectures and clinically relevant cases developed by an expert faculty of HIV/AIDS clinicians and researchers.

Learning Objectives

After participating in the activity, learners will be better able to:

  • Assess frailty in older people with HIV
  • Conduct neurocognitive assessments in older patients with HIV
  • List strategies for preventing and managing cardiovascular disease in older patients with HIV and
  • Identify, manage, and prevent polypharmacy in older patients with HIV
  • Identify key primary care concerns for the aging population
  • Describe evidence-based approaches that can be used to treat and manage chronic pain in older patients with HIV

Conflicts of Interest

In the interest of maintaining the independence of its continuing education activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they or their spouses or partners have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved prior to the continuing education activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA continuing education activity.

The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Registration

Who Should Attend

This course is designed for physicians who are actively involved in the medical care of people with HIV infection and:

  • Have a solid, working knowledge of HIV disease management
  • Provide comprehensive or specialty care for patients with HIV infection
  • Are currently active in HIV research

This activity is also relevant to nurse practitioners, registered nurses, physician assistants, registered pharmacists, and other health professionals.

Representatives and employees of commercial companies (eg, pharmaceutical, diagnostic, medical products, advertising, insurance, investment, and communications firms) must contact the IAS–USA regarding registration procedures.

Cancellation Policy

Cancellation requests must be made 8 or more days before the date of an activity. All refunds will be processed minus a $15.00 processing charge. Regrettably, any cancellation requests received within a week before the course will not be eligible for the partial refund.

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Points

ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nursing Credits

These activities are eligible for ANCC credit, see final CNE activity announcement for specific details.

Pharmacy Credits

Accreditation Council for Pharmacy Education logo These activities are eligible for ACPE credit, see final CPE activity announcement for specific details.

Grant Support

This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from ineligible companies. Per IAS–USA policy, any effort that uses grants from ineligible companies must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.

PLATINUM SUPPORTERS

Gilead Sciences, Inc.
Merck & Co., Inc.
ViiV Healthcare

SILVER SUPPORTER

Janssen Therapeutics

BRONZE SUPPORTER

Theratechnologies Inc.

Frequently Asked Questions

View our list of FAQs about attending a webinar.

Further Questions?
Please contact the registration department at registration@iasusa.org or 415-544-9400.